Side-effect avoiding treatment shows early promise against breast cancer in mice

New experimental evidence suggests that substances known as narrow-spectrum Wnt signaling inhibitors—which could have fewer side effects than other related substances—are capable of suppressing the growth of breast cancer tumors in mice. Aina He of Shanghai Jiaotong University Affiliated Sixth People’s Hospital, China, and colleagues presented these findings November 9 in the open access journal PLOS Biology.